Animal pharm

Article Abstract:

The animal health company Merial was formed as a joint venture between two competitor companies Merck and Rhone-Poulenc SA. The two firms initially invested $120 million into Merial when it was set up in Aug 1997. Merial now runs as a stand alone business and had growth of 4.9% for its first year. The management of Merial have worked hard to ensure the company performs as a partnership and it is run by an equal number of directors from both parent companies. Both firms had seen the possibility of joining together to make a animal health company apart from their core life science operations.

Biochemistry, Research and Development in the Physical, Engineering, and Life Sciences, Management, Biotechnology industry, Biotechnology industries, Joint ventures, Company Profile, Rhone-Poulenc S.A., Merck & Company Inc., Merial

---

An accident waiting to happen?

Article Abstract:

Many potential company sales activities are not using the services of commercial due diligence (CDD) specialists because of the expense and lack of confidence in financial advisers. Up to 25 million pounds sterling was earned by due diligence specialists in 1997, with the majority of deals over 7 million pounds sterling taking up the service. CCD accountants spend an average three weeks working on a deal, with the average fee ranging from 35,000 pounds sterling up to 100,000 pounds sterling.

Consumer Lending, Personal credit institutions, Consumer Finance Institutions, Services, Commercial finance companies, Consumer finance companies

---

Investing in a healthy market

Article Abstract:

The recapitalization of Swedish healthcare company M&M Medical was achieved through the intervention of HSBC Private Equity, which provided the financial support required to build the company and develop strategic opportunities within the sector. M&M Medical is a provider of private healthcare, specializing in diagnostic and medical treatments. The refunding has allowed a greater level of investment in future technologies.

Case studies, Finance, Financial planning, M&M Medical

Similar abstracts:

• Abstracts: Bonded by brands. German group moves on Balkan markets
• Abstracts: TRIGAT tangles. No longer in the dark. Joint bid for Huzar
• Abstracts: Grafobal has a plant in Slany. Crankshafts from Kladno
• Abstracts: Industrial actions. Rotten, but getting less so. Taming leviathan
• Abstracts: Making aid work. Silent sting. White man's shame

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.